People need to realize the importance of the scheduled presentations at ASCO. ASCO constitutes peer review of the data, until that occurs the company isn't supposed to discuss the data in depth. I believe after ASCO they'll be able to show and discuss what was in the presentation.
There are a limited number of late breaking Abstracts accepted at ASCO, we should recognize that it's important that ours was one of them.
Market Data 
Markets 
AI
